Innospera Pharma

📍 Montreal, Canada👥 6 employees💰 Last funded Dec 2024
Biotechnology Research🌐 innospera.com
Website LinkedIn
Innospera is a privately-owned biotech company near clinical stage, developing small molecule modulators of 7-transmembrane receptors involved in a broad range of chronic and fibrotic conditions. The company’s lead drug candidates target key G-protein coupled receptors (GPCR) involved in fibroaging and inflammaging, including idiopathic pulmonary fibrosis (IPF), a condition with dire short-term prognosis. Innospera also develops multiple other modulators with promising potency in other medical conditions with pressing unmet needs. For more information, visit innospera.com
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
2
Frequently asked questions
Who invested in Innospera Pharma?
Innospera Pharma has 2 investors on record on gritt.io.
When did Innospera Pharma last raise funding?
The most recent investment in Innospera Pharma recorded on gritt.io was in December 2024.
What industry is Innospera Pharma in?
Innospera Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Innospera Pharma based?
Innospera Pharma is headquartered in Montreal, Canada.